New FP7 eHealth Project - DebugIT

The DebugIT project is a large -scale integrating project funded within the 7th EU Framework Programme (FP7). The main objectives are to build IT tools that should have significant impacts for the monitoring and control of infectious diseases and antimicrobial resistances in Europe. This will be realized by building a technical and semantic infrastructure able to:
  • share heterogeneous clinical data sets from different hospitals in different countries, with different languages and legislations,
  • analyze large amounts of this clinical data with advanced multimedia data mining, and
  • apply the obtained knowledge for clinical decisions and outcome monitoring.

The DebugIT project, with its innovative approach, is an example of how ICT tools can be used to address the emerging challenges in healthcare. The DebugIT project addresses several of the overriding call topics at once by tackling the problems around antibiotics and of antimicrobial resistance of infectious diseases in an international consortium uniting world class research facilities, SMEs and industry partners.

It is an example of partnering at the European level to keep pace with soaring research costs by making use of complex IT technology technologies. It addresses the main socio-economic challenge in healthcare, namely to make Europe's healthcare systems safer and sustainable.

The research consortium includes public and private research institutions, university and teaching hospitals, industry and SMEs. The results of the application of the RTD will lead to higher patient safety and thereby fewer, more targeted intervention and fewer days in hospital. It means improving the overall productivity and efficiency of healthcare systems, delivering more personalised care solutions by allowing the actual patient data to be fed immediately into the system. It will therefore improving the Qquality of Life for patients and save their lives due to better, shorter and more targeted treatment. Patient safety is optimised through medical interventions with respect to treatment of infectious diseases and prescribing and administering antibiotics. The decision support will help avoid medical and other healthcare errors.

For further information, please visit:
http://www.debugit.eu

Related article:

Most Popular Now

Researchers Capture First Images of Oxyg…

Oxygen in cancer tumors is known to be a major factor that helps radiation therapy be successful. Hypoxia, or starvation of oxygen, in solid tumors is also thought to be...

VTT Makes New Investments in Digital Hea…

VTT is launching new research activities in the area of digital health as part of the growing wellbeing and health technology ecosystem in Kuopio. The new initiative aims to create...

A New Method of Artificial Intelligence …

Despite the immense progress in the field of AI in recent years, we are still very far from human intelligence. Indeed, if current AI techniques allow to train computer agents...

FDA Informs Health Care Providers, Facil…

Today, the U.S. Food and Drug Administration is issuing a safety communication informing health care providers, facilities and patients about cybersecurity vulnerabilities identified for certain GE Healthcare Clinical Information Central...

eHealthWeek 2020 Croatia - Trusted Infor…

15 - 17 April 2020, Rovinj, Croatia. In its capacity of hosting the upcoming Presidency of the Council of the European Union, the Croatian Ministry of Health is in preparations to...

Siemens Healthineers Presents Solutions …

CT scanners with intelligent user guidance, AI-based software assistants for MRI and a lab system that revolutionizes workflows: Siemens Healthineers is showcasing its products and solutions according to the motto...

NHS IT Chiefs Set the Stage for a Year o…

3 - 4 March 2019, London, United Kingdom. NHS technology leaders are to kick off the second-ever Digital Health Rewired Conference and Exhibition on 3 - 4 March at the Olympia...

PatchAi Startup has Arrived in the Marke…

PatchAi - a startup that offers, thanks to Artificial Intelligence and Machine Learning, an empathic virtual assistant to patients participating in clinical trials - announced that it has closed two...

Digital Health App Medicus AI Earns CE C…

Medicus AI, the Vienna-based health tech company, has received a ​Class I Medical Device CE Mark for its mobile application. The CE certification mark confirms that Medicus AI conforms to...

Refining Breast Cancer Classification by…

Breast cancer progression can vary significantly between patients. Even within the same tumor, different areas may be composed of different types of cells and characterized by different tumor structures. This...

Human Body-on-Chip Platform Enables In V…

Drug development is an extremely arduous and costly process, and failure rates in clinical trials that test new drugs for their safety and efficacy in humans remain very high. According...

FDA Authorizes Marketing of First Cardia…

Today, the U.S. Food and Drug Administration authorized marketing of software to assist medical professionals in the acquisition of cardiac ultrasound, or echocardiography, images. The software, called Caption Guidance, is...